FGFR2 in the Development and Progression of Cutaneous Squamous Cell Cancer
Molecular Carcinogenesis · 2025
DOI: 10.1002/mc.23835 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Carcinogenesis, 2025. Verfasst von Ethan M Kallenberger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 2, Skin Neoplasms, Carcinoma, Squamous Cell, Disease Progression. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Cutaneous squamous cell carcinoma (cSCC) is an increasingly common malignancy of the skin and the leading cause of death from skin cancer in adults over the age of 85. Fibroblast growth factor receptor 2 (FGFR2) has been identified as an important effector of signaling pathways that lead to the growth and development of cSCC. In recent years, there have been numerous studies evaluating the role FGFR2 plays in multiple cancers, its contribution to resistance to anticancer therapy, and new drugs that may be used to inhibit FGFR2. This review will provide an overview of our current understanding of FGFR2 and potential mechanisms in which we can target FGFR2 in cSCC. The goals of this review are the following: (1) to highlight our current knowledge of the role of FGFR2 in healthy skin and contrast this with its role in the development of cancer; (2) to further explain the specific molecular mechanisms that FGFR2 uses to promote tumorigenesis; (3) to describe how FGFR2 contributes to more invasive disease; (4) to describe its immunosuppressive effects in skin; and (5) to evaluate its effect on current anticancer therapy and discuss therapies on the horizon to target FGFR2 related malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Oto/HNS, Health Sciences Center, Louisiana State University, Shreveport, Louisiana, USA.
- Department of Pharmacology, University of Texas, Austin, Texas, USA.
ORCID-Profile: John DiGiovanni
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Kallenberger, E. M., Khandelwal, A., Nath, P., Nguyen, S. A., DiGiovanni, J., & Nathan, C. A. (2025). FGFR2 in the Development and Progression of Cutaneous Squamous Cell Cancer. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23835
Vancouver
Kallenberger EM, Khandelwal A, Nath P, Nguyen SA, DiGiovanni J, Nathan CA. FGFR2 in the Development and Progression of Cutaneous Squamous Cell Cancer. Molecular Carcinogenesis. 2025. doi:10.1002/mc.23835
BibTeX
@article{Kallenberger2025,
author = {Kallenberger, Ethan M and Khandelwal, Alok and Nath, Priyatosh and Nguyen, Shaun A and DiGiovanni, John and Nathan, Cherie-Ann},
title = {FGFR2 in the Development and Progression of Cutaneous Squamous Cell Cancer},
journal = {Molecular Carcinogenesis},
year = {2025},
doi = {10.1002/mc.23835}
}
EUVIMED